Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

This study has been terminated.
(Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology indications.)
Information provided by (Responsible Party):
Takeda Identifier:
First received: February 26, 2008
Last updated: November 29, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)